126 related articles for article (PubMed ID: 28192252)
21. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
[TBL] [Abstract][Full Text] [Related]
22. 188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia.
Bunjes D
Leuk Lymphoma; 2002 Nov; 43(11):2125-31. PubMed ID: 12533037
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
[TBL] [Abstract][Full Text] [Related]
24. Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia.
Wong JYC; Filippi AR; Scorsetti M; Hui S; Muren LP; Mancosu P
Lancet Oncol; 2020 Oct; 21(10):e477-e487. PubMed ID: 33002443
[TBL] [Abstract][Full Text] [Related]
25. [Significance of intensified conditioning regimen for allogeneic hematopoietic stem cell transplantation for treatment of acute leukemias].
Shigematsu A
Rinsho Ketsueki; 2011 Aug; 52(8):667-73. PubMed ID: 21897073
[No Abstract] [Full Text] [Related]
26. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
[TBL] [Abstract][Full Text] [Related]
27. Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?
Paubelle E; Ducastelle-Leprêtre S; Labussière-Wallet H; Nicolini FE; Barraco F; Plesa A; Salles G; Wattel E; Thomas X
Ann Hematol; 2017 Mar; 96(3):363-371. PubMed ID: 28011984
[TBL] [Abstract][Full Text] [Related]
28. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
[TBL] [Abstract][Full Text] [Related]
29. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia.
Rodriguez V; Anderson PM; Litzow MR; Erlandson L; Trotz BA; Arndt CA; Khan SP; Wiseman GA
Leuk Lymphoma; 2006 Aug; 47(8):1583-92. PubMed ID: 16966270
[TBL] [Abstract][Full Text] [Related]
30. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
[TBL] [Abstract][Full Text] [Related]
31. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
[TBL] [Abstract][Full Text] [Related]
32. Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Eder S; Canaani J; Beohou E; Labopin M; Sanz J; Arcese W; Or R; Finke J; Cortelezzi A; Beelen D; Passweg J; Socié G; Gurman G; Aljurf M; Stelljes M; Giebel S; Mohty M; Nagler A
Am J Hematol; 2017 Oct; 92(10):997-1003. PubMed ID: 28614903
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission.
Baron F; Storb R
Curr Opin Hematol; 2007 Mar; 14(2):145-51. PubMed ID: 17255792
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
35. [Containing total marrow irradiation conditioning regimen for patients with leukemia undergoing hematopoietic stem cell transplantation].
Zhao XY; Wang HF
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):525-528. PubMed ID: 32654472
[No Abstract] [Full Text] [Related]
36. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
[TBL] [Abstract][Full Text] [Related]
37. Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.
Epperla N; Pasquini M; Pierce K; Drobyski WR; Rizzo JD; Horowitz MM; Saber W; Zellner K; Ramirez S; Bartz K; Raj RV; Hari PN; Hamadani M
Bone Marrow Transplant; 2017 Jan; 52(1):147-150. PubMed ID: 27479688
[No Abstract] [Full Text] [Related]
38. [Salvaged allogeneic hematopoietic stem cell transplantation for refractory/recurrent acute myeloid leukemia].
Wang JB; Wu T; DA WM; Tong CR; Sun Y; Zhao YL; Yin YM; Cao XY; Lu Y; Gao YQ; Zhou JR; Zhang JP; Luo RM; Zou W; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):467-70. PubMed ID: 22967382
[TBL] [Abstract][Full Text] [Related]
39. Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.
Hamidieh AA; Monzavi SM; Kaboutari M; Behfar M; Esfandbod M
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2110-2117. PubMed ID: 28870778
[TBL] [Abstract][Full Text] [Related]
40. Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Hui S; Brunstein C; Takahashi Y; DeFor T; Holtan SG; Bachanova V; Wilke C; Zuro D; Ustun C; Weisdorf D; Dusenbery K; Verneris MR
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1110-1116. PubMed ID: 28396164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
